The role of ATP citrate-lyase in the metabolic regulation of plasma lipids. Hypolipidaemic effects of SB-204990, a lactone prodrug of the potent ATP citrate-lyase inhibitor SB-201076.
about
Differential gene expression patterns in cyclooxygenase-1 and cyclooxygenase-2 deficient mouse brainBempedoic Acid (ETC-1002): an Investigational Inhibitor of ATP Citrate LyaseATP-citrate lyase deficiency in the mouseDeficiency in hepatic ATP-citrate lyase affects VLDL-triglyceride mobilization and liver fatty acid composition in miceCell walls of Saccharomyces cerevisiae differentially modulated innate immunity and glucose metabolism during late systemic inflammation.LDL-cholesterol reduction in patients with hypercholesterolemia by modulation of adenosine triphosphate-citrate lyase and adenosine monophosphate-activated protein kinaseATP citrate lyase mediates resistance of colorectal cancer cells to SN38.Recent developments in the treatment of atherosclerosis.AMP-activated protein kinase and ATP-citrate lyase are two distinct molecular targets for ETC-1002, a novel small molecule regulator of lipid and carbohydrate metabolism.Role of cystathionine beta synthase in lipid metabolism in ovarian cancerNovel enzyme reactions related to the tricarboxylic acid cycle: phylogenetic/functional implications and biotechnological applications.Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver DiseaseHooked on fat: the role of lipid synthesis in cancer metabolism and tumour development.Acetate produced in the mitochondrion is the essential precursor for lipid biosynthesis in procyclic trypanosomes.Cytosolic functions of MORC2 in lipogenesis and adipogenesisInhibitors of fatty acid synthesis in prokaryotes and eukaryotes as anti-infective, anticancer and anti-obesity drugs.Targeting the latest hallmark of cancer: another attempt at 'magic bullet' drugs targeting cancers' metabolic phenotype.The roles of sterol regulatory element-binding proteins in the transactivation of the rat ATP citrate-lyase promoter.Fatty Acids and Breast Cancer: Make Them on Site or Have Them Delivered.The contribution of the citrate pathway to oxidative stress in Down syndrome.Metabolic control of epigenetics in cancer.ATP-Citrate Lyase Controls a Glucose-to-Acetate Metabolic SwitchATP-citrate lyase reduction mediates palmitate-induced apoptosis in pancreatic beta cells.Targeting ACLY sensitizes castration-resistant prostate cancer cells to AR antagonism by impinging on an ACLY-AMPK-AR feedback mechanism.Specific killing of Rb mutant cancer cells by inactivating TSC2.Liver-specific ATP-citrate lyase inhibition by bempedoic acid decreases LDL-C and attenuates atherosclerosis.A novel direct homogeneous assay for ATP citrate lyaseAbrogation of hepatic ATP-citrate lyase protects against fatty liver and ameliorates hyperglycemia in leptin receptor-deficient mice.Immunochemical characterization of the functional constituents of Tripterygium wilfordii contributing to its anti-inflammatory property.Lipid Metabolism and Lipid Droplets in Pancreatic Cancer and Stellate Cells.Small-Molecule Modulation of Lipid-Dependent Cellular Processes against Cancer: Fats on the Gunpoint
P2860
Q21184137-C3795F6D-2FE1-4C11-8764-6831E357E44EQ28067422-FDE904DB-7D57-4A67-B187-4C40E14C3337Q33923761-64678AFD-1019-469F-A99D-7FAD01330E30Q34053069-38F94850-7318-4A4C-91DA-D9327F20087EQ34137678-449D6DF1-4338-41D7-A498-370CF89D69E9Q34171169-25FB95DC-032C-438A-9764-5BE039D123ABQ34996926-0CCD4EBE-7488-4E8F-9936-C2E3507769B5Q36434617-59D5A426-40C9-40AB-A32D-775B26D6D4B5Q36462041-C83E4673-202B-477E-895A-2C21FA82CCB5Q36545745-9A5D292D-37A9-4B54-88B8-1F236256F720Q36749349-C07991A3-95FB-4000-B011-F224BAB47A0CQ36818384-1F4E1137-D30B-4069-9CF3-2D89B5BA0EA8Q37287417-323F91B8-7D59-4ECC-9322-626FBC701714Q37293302-DB07D3EC-81FE-438C-B626-1B84FA874067Q37583000-9ECA4E7A-8A7D-424A-BDB8-F48D3656E09FQ38019608-CBCBB286-39BC-4E64-877E-A8B2B1433122Q38058130-649CC4D6-F4F2-4E97-8E9F-C1A6DA4961AEQ38526403-1378BF2C-B86C-4AB2-924B-1B1E962B98C6Q38722530-49CC6B71-C516-4AC7-B8B7-F12BEC369246Q38733639-CD0FE026-AD7A-4164-BD66-41FD9189A75EQ38955875-EC14FA90-9E01-4814-8235-DF48EEF3B128Q39270542-D22F3CC8-EC4F-484E-8DE1-B9E1858260EFQ39669833-A9B64433-8D09-4CF5-830D-A1D7FD93CBD7Q39986242-B697C3DD-FA63-43E6-B16E-7FA7C09C94A0Q40669345-52B84D43-75BD-4CE0-BF3E-60E1678AC585Q41885927-B287A0A0-697F-4E44-8BF9-53E67B241639Q42549089-118D4B78-7BD7-41DA-BCFC-62555AF3AF2CQ46141813-205B7DD0-3CF5-4E90-962F-417499CC4186Q46875188-15B1F108-B990-450D-AD10-387D3550683BQ47754576-99A1821E-0A7C-4929-B6E7-F21E91489DFEQ57169171-0FB465CB-B7A4-45B5-8C72-AEB36BF086FA
P2860
The role of ATP citrate-lyase in the metabolic regulation of plasma lipids. Hypolipidaemic effects of SB-204990, a lactone prodrug of the potent ATP citrate-lyase inhibitor SB-201076.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
The role of ATP citrate-lyase ...... ate-lyase inhibitor SB-201076.
@en
The role of ATP citrate-lyase ...... ate-lyase inhibitor SB-201076.
@nl
type
label
The role of ATP citrate-lyase ...... ate-lyase inhibitor SB-201076.
@en
The role of ATP citrate-lyase ...... ate-lyase inhibitor SB-201076.
@nl
prefLabel
The role of ATP citrate-lyase ...... ate-lyase inhibitor SB-201076.
@en
The role of ATP citrate-lyase ...... ate-lyase inhibitor SB-201076.
@nl
P2093
P2860
P356
P1433
P1476
The role of ATP citrate-lyase ...... ate-lyase inhibitor SB-201076.
@en
P2093
Berkhout TA
Camilleri P
Gribble AD
P2860
P304
P356
10.1042/BJ3340113
P407
P478
334 ( Pt 1)
P577
1998-08-01T00:00:00Z